Refine Search
(297)
(558)
(941)
(1810)

NEW CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – China

  • $1,995
  • January 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – China”. The report is an essential source of information and analysis on the healthcare, regulator...

NEW Rheumatoid Arthritis: Epidemiology Forecast to 2027

  • $3,995
  • January 2019
Add to Basket Quick View Add to Saved List

Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body. In RA, the body’s immu...

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q3 2018

  • $1,500
  • January 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q3 2018” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and finan...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – UK

  • $1,995
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – UK”. The report is an essential source of information and analysis on the healthcare, regulatory a...

Contraceptives: Opportunity Analysis and Forecasts to 2027

  • $10,995
  • December 2018
Add to Basket Quick View Add to Saved List

Hormonal contraceptives are primarily used to prevent unintended pregnancy; however, some of these contraceptives are also approved or used off-label for other health conditions, particularly menstrual-related disorders. This report focuses on ...

Vaccines for Emerging Infectious Diseases: Funding, R&D, and Global Partnership Strategies

  • $7,995
  • December 2018
Add to Basket Quick View Add to Saved List

Emerging infectious diseases (EIDs) are characterized by unpredictable incidence and clinical patterns that pose unique challenges for vaccine development. As outbreaks of Ebola virus, Zika virus, and other EIDs have occurred in the past decade...

Biomarkers and Companion Diagnostics in Oncology

  • $7,995
  • December 2018
Add to Basket Quick View Add to Saved List

A biomarker is a defined molecular characteristic, for example a genetic mutation, that can tell a physician more about a patient’s disease state, or how they might respond to treatment. Predictive biomarkers indicate how likely a patient is to...

Neuroimmunology Drug Development

  • $7,995
  • December 2018
Add to Basket Quick View Add to Saved List

Neuroimmunology is expected to be an area that will witness strong growth in the future due to factors such as deeper understanding of the underlying disease pathology, advancements in neurogenetics, and potential of these drugs that can contri...

PharmSource - M&A in the Contract Manufacturing Industry: Implications and Outlook – 2018 Edition

  • $4,995
  • December 2018
Add to Basket Quick View Add to Saved List

This report is the 2nd edition of our analysis of Mergers and Acquisitions in the contract manufacturing industry. PharmSource is the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.

Age-Related Macular Degeneration: Competitive Landscape to 2026

  • $3,495
  • December 2018
Add to Basket Quick View Add to Saved List

Age-Related macular degeneration (AMD) is one of the leading cause of vision loss among people ages 50 and over in the developed world, characterized by the deterioration or breakdown of the macula, a small area of the central retina needed for...

Glaucoma: Competitive Landscape to 2026

  • $3,495
  • December 2018
Add to Basket Quick View Add to Saved List

Glaucoma is a common, asymptomatic group of eye diseases that causes damage to the eye’s optic nerve, resulting in progressive, irreversible vision loss. Glaucoma is one of the leading causes of blindness worldwide, especially in elderly people...

Psoriatic Arthritis: Competitive Landscape to 2026

  • $3,495
  • December 2018
Add to Basket Quick View Add to Saved List

Psoriatic arthritis is a chronic immune-mediated arthritis that typically affects the large joints, including those of the lower extremities, the distal joints of the fingers and toes, the back, and sacroiliac joints of the pelvis. Up to 30% of...

Cloud Computing in Healthcare - Thematic Research

  • $1,950
  • December 2018
Add to Basket Quick View Add to Saved List

Cloud computing (including IaaS, PaaS, SaaS, private, and hybrid cloud services, managed cloud services and cloud management platforms) accounted for 7.6% of a global information and communications technology (ICT) market that was worth $3 tril...

PharmSource - Catching the Next Wave: How Much Have CMOs Benefited from Biosimilars – 2018 Edition

  • $4,995
  • December 2018
Add to Basket Quick View Add to Saved List

Biosimilars are drugs that are highly similar but not identical to branded “innovator” biologics: large molecule, immunogenic drugs produced from living cells. “Innovator” biologics are the first to be approved, and when their patent protection...

Plaque Psoriasis: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • December 2018
Add to Basket Quick View Add to Saved List

Psoriasis is an incurable, chronic and systemic inflammatory skin disorder with a prevalence of 2–3% worldwide. The exact causes of psoriasis is unknown, although it is believed that environmental factors, skin barrier disruptions, and immune d...

Report Catalogue

Strategic Insight Reports

Market Analysis Reports

Databooks